Home/Filings/4/0001144204-11-056651
4//SEC Filing

Hohn David C 4

Accession 0001144204-11-056651

CIK 0001318641other

Filed

Oct 5, 8:00 PM ET

Accepted

Oct 6, 7:43 AM ET

Size

4.7 KB

Accession

0001144204-11-056651

Insider Transaction Report

Form 4
Period: 2011-10-04
Hohn David C
Director
Transactions
  • Purchase

    Common Stock, par value $0.005 per share

    2011-10-04$2.36/sh+1,000$2,3601,000 total
Footnotes (1)
  • [F1]The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2011.

Issuer

CLEVELAND BIOLABS INC

CIK 0001318641

Entity typeother

Related Parties

1
  • filerCIK 0001523106

Filing Metadata

Form type
4
Filed
Oct 5, 8:00 PM ET
Accepted
Oct 6, 7:43 AM ET
Size
4.7 KB